New York S 5786: Requires certain eligible persons or entities to acquire and possess opioid antagonists

Bill Text

Bill Search and Legislative Information | New York State Assembly 

• 

• 

• 

• 

• 

• 

• 

• 

 Skip to main content 

 New York State Assembly

 Speaker Carl E. Heastie

 --> 
 --> 

 --> 

• 
 Assembly Members 

• 
 Legislative Info 

• 
 Public Hearings 

• 
 Speaker's Press 

• 
 Assembly Reports 

• 
 Committees & More 

• Bill Search Home
• Laws
• Legislative Calendar
• Public Hearing Schedule
• Assembly Calendars
• Assembly Committee Agenda 

 Javascript must be enabled to properly view this page. 

 Bill No.: 

• Summary 
• Actions 
• Committee&nbspVotes 
• Floor&nbspVotes 
• Memo 
• Text 
• LFIN 
• Chamber&nbspVideo/Transcript 
S05786 Summary:

BILL NOS05786 

&nbsp

SAME ASSAME AS A01748

&nbsp

SPONSORSEPULVEDA

&nbsp

COSPNSR

&nbsp

MLTSPNSR

&nbsp

Add §3000-g, Pub Health L

&nbsp

Requires certain eligible persons or entities to acquire and possess opioid antagonists for emergency treatment of a person appearing to experience an opioid-related overdose.

Go to top S05786 Actions:

BILL NOS05786 

&nbsp

03/03/2025REFERRED TO HEALTH

01/07/2026REFERRED TO HEALTH

Go to topS05786 Committee&nbspVotes:

Go to topS05786 Floor&nbspVotes:

There are no Assembly votes for this bill in this legislative session.

Go to topS05786 Text:

 STATE OF NEW YORK
 ________________________________________________________________________

 5786

 2025-2026 Regular Sessions

 IN SENATE

 March 3, 2025
 ___________

 Introduced by Sen. SEPULVEDA -- read twice and ordered printed, and when
 printed to be committed to the Committee on Health

 AN ACT to amend the public health law, in relation to requiring certain
 eligible persons or entities to acquire and possess opioid antagonists

 The People of the State of New York, represented in Senate and Assem-
 bly, do enact as follows:

 1 Section 1. The public health law is amended by adding a new section
 2 3000-g to read as follows:
 3 § 3000-g. Opioid antagonist. 1. Definitions. As used in this section:
 4 (a) "Eligible person or entity" means (i) an ambulance service or
 5 advanced life support first response service; a certified first respon-
 6 der, emergency medical technician, or advanced emergency medical techni-
 7 cian, who is employed by or an enrolled member of any such service; (ii)
 8 a children's overnight camp as defined in subdivision one of section
 9 thirteen hundred ninety-two of this chapter, a summer day camp as
 10 defined in subdivision two of section thirteen hundred ninety-two of
 11 this chapter, a traveling summer day camp as defined in subdivision
 12 three of section thirteen hundred ninety-two of this chapter; or a
 13 person employed by such a camp; (iii) a school district, board of coop-
 14 erative educational services, county vocational education and extension
 15 board, charter school, non-public elementary and secondary school,
 16 colleges, and universities in this state; or any person employed by any
 17 such entity, or employed by a contractor of such an entity while
 18 performing services for the entity; (iv) a government office; an educa-
 19 tional institution or after-school program; a community center; a
 20 publicly or privately operated shelter; or any person employed by any
 21 such entity, or employed by a contractor of such an entity while
 22 performing services for the entity; (v) a correctional facility, a coun-
 23 ty jail, a police station, or a fire station; a pharmacy, doctor's
 24 office; or any person employed by any such entity, or employed by a
 25 contractor of such an entity while performing services for the entity;
 26 and (vi) any other person or entity designated or approved, or in a
 27 category designated or approved pursuant to regulations of the commis-
 28 sioner in consultation with other appropriate agencies.

 EXPLANATION--Matter in italics (underscored) is new; matter in brackets
 [ ] is old law to be omitted.
 LBD03989-01-5

 S. 5786 2

 1 (b) "Opioid antagonist" means a drug approved by the Food and Drug
 2 Administration that, when administered, negates or neutralizes in whole
 3 or in part the pharmacological effects of an opioid in the body. "Opioid
 4 antagonist" shall be limited to naloxone and other medications approved
 5 by the department for such purpose.
 6 (c) "Health care practitioner" means a health care practitioner
 7 licensed, certified, or authorized to practice under title eight of the
 8 education law who is authorized thereby to administer drugs, and who is
 9 acting within the scope of their practice.
 10 2. Possession and use. (a) Any eligible person or entity shall acquire
 11 and possess and may use an opioid antagonist for emergency treatment of
 12 a person appearing to experience an opioid-related overdose.
 13 (b) An eligible person or entity shall possess at least two provisions
 14 of an opioid antagonist at all times.
 15 (c) An eligible person or entity shall designate one or more individ-
 16 uals who have completed the training required by paragraph